TY - JOUR
TI - Plasma adiponectin levels and five-year survival after first-ever
ischemic stroke
AU - Efstathiou, SP
AU - Tsioulos, DI
AU - Tsiakou, AG
AU - Gratsias, YE and
AU - Pefanis, AV
AU - Mountokalakis, TD
JO - ISRN Stroke
PY - 2005
VL - 36
TODO - 9
SP - 1915-1919
PB - Lippincott, Williams & Wilkins
SN - 2090-9454
TODO - 10.1161/01.STR.0000177874.29849.f0
TODO - prognosis; stroke, ischemic; survival
TODO - Background and Purpose - This study aimed to investigate the association
between plasma adiponectin levels and 5-year survival after first-ever
ischemic stroke.
Methods - Plasma adiponectin measured within 24 hours after first-ever
ischemic stroke was related to 5-year outcome. The Kaplan-Meier
technique was applied in survival analysis, and the Cox proportional
hazards model was used to evaluate the relationship between risk factors
and prognosis.
Results - The probabilities of death were 92.8%, 52.5%, and 10.5% (P
< 0.001) for patients stratified according to tertiles of adiponectin (<
4 mu g/mL, 4 to 7 mu g/mL, and > 7 mu g/mL, respectively). The relative
risk of death was 8.1 (95% CI, 3.1, 24.5; P < 0.001) for individuals
with adiponectin levels in the lowest tertile compared with the upper
tertile. Adiponectin < 4 mu g/mL (hazard ratio [HR], 5.2; 95% CI,
2.1, 18.4; P < 0.001), score > 15 in the National Institutes of Health
Stroke Scale (HR, 3.6; 95% CI, 1.7, 15.9; P < 0.001), and coronary
heart disease (HR, 2.9; 95% CI, 1.5, 12.3; P < 0.001) were
independently associated with mortality.
Conclusions - Low plasma adiponectin is related to an increased risk of
5-year mortality after first-ever ischemic stroke, independently of
other adverse predictors.
ER -